News
HSBC upgraded Eli Lilly to Hold from Reduce, saying its bear case has now run its course and the risk-reward profile looks more balanced.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback